Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 10, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals under the Company's ShareReward Plan on August 9, 2005, at a price of GBP 13.24 per share. The transactions involved both personal contributions and company matching contributions:
- Mr. J S Heslop: Acquired 9 shares (personal) and 9 shares (company match).
- Mr. R M Bondy: Acquired 9 shares (personal) and 9 shares (company match).
- Mr. A P Witty: Acquired 9 shares (personal) and 9 shares (company match).
- Mrs. J V Younger: Acquired 9 shares (personal) and 9 shares (company match).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Key Facts for Investor Verification
- Share price for the transaction was GBP 13.24 per Ordinary Share.
- Transactions occurred on August 9, 2005, under the ShareReward Plan entered into on October 5, 2001.
- Total shares acquired per individual listed was 18 (9 personal + 9 company match).
- The filing was signed by Victoria Llewellyn as the Authorised Signatory on August 10, 2005.